{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:30:30Z","timestamp":1792074630303,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["311292"],"award-info":[{"award-number":["311292"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["K2014-62X-22525-01-4"],"award-info":[{"award-number":["K2014-62X-22525-01-4"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Research Area MultiPark"},{"DOI":"10.13039\/501100003173","name":"Crafoord Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Alzheimer Foundation"},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sk\u00e5ne Research Hospital"},{"DOI":"10.13039\/501100006075","name":"Greta and Johan Kock Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Koch\u2019s Foundation"},{"name":"Swedish federal government"},{"name":"Medical Training and Research Agreement"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.neurobiolaging.2016.11.017","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T01:46:17Z","timestamp":1480902377000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"special_numbering":"C","title":["Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype"],"prefix":"10.1016","volume":"51","author":[{"given":"Shorena","family":"Janelidze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Hertze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-8402","authenticated-orcid":false,"given":"Katarina","family":"N\u00e4gga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Wennstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"van Westen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-iii-r","year":"1987"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib3","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1172\/JCI60842","article-title":"Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease","volume":"122","author":"Argaw","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib6","first-page":"1","article-title":"Mixtools: an R Package for analyzing finite mixture models","volume":"32","author":"Benaglia","year":"2009","journal-title":"J.\u00a0Stat. Softw."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2796.1993.tb00647.x","article-title":"The Malmo diet and cancer study. Design and feasibility","volume":"233","author":"Berglund","year":"1993","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","article-title":"Lack of widespread BBB disruption in Alzheimer's disease models: focus on therapeutic antibodies","volume":"88","author":"Bien-Ly","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","article-title":"Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors","volume":"81","author":"Blennow","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1600-0404.1991.tb04675.x","article-title":"White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors","volume":"83","author":"Blennow","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib11","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/01.wnl.0000262031.18018.1a","article-title":"Blood-brain barrier impairment in Alzheimer disease: stability and functional significance","volume":"68","author":"Bowman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0455.43.s.428.1.x","article-title":"Magnetic resonance imaging in dementia. A study of brain white matter changes","volume":"428","author":"Bronge","year":"2002","journal-title":"Acta Radiol. Suppl."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000321965","article-title":"Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome","volume":"65","author":"Brouns","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3233\/JAD-122155","article-title":"Amyloid-beta interacts with blood-brain barrier function in dementia: a systematic review","volume":"35","author":"Burgmans","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","article-title":"The molecular constituents of the blood-brain barrier","volume":"38","author":"Chow","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1468-1331.2012.03776.x","article-title":"Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates","volume":"19","author":"De Reuck","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.clineuro.2012.11.005","article-title":"Prevalence of cerebrovascular lesions in patients with Lewy body dementia: a neuropathological study","volume":"115","author":"De Reuck","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","article-title":"Vascular dysfunction in the pathogenesis of Alzheimer's disease\u2014a review of endothelium-mediated mechanisms and ensuing vicious circles","volume":"82","author":"Di Marco","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J.\u00a0Psychiatr. Res."},{"issue":"Suppl 12","key":"10.1016\/j.neurobiolaging.2016.11.017_bib21","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20535","article-title":"How to diagnose dementia with Lewy bodies: state of the art","volume":"20","author":"Geser","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/jamaneurol.2013.3841","article-title":"Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown","volume":"70","author":"Halliday","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00125-006-0485-z","article-title":"Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases","volume":"50","author":"Hawkins","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/WNL.0000000000002151","article-title":"Increased CSF biomarkers of angiogenesis in Parkinson disease","volume":"85","author":"Janelidze","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib25","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma beta-amyloid in Alzheimer's disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib26","doi-asserted-by":"crossref","first-page":"e84405","DOI":"10.1371\/journal.pone.0084405","article-title":"Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia","volume":"8","author":"Karch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib27","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jns.2015.10.011","article-title":"Increased albumin CSF\/serum ratio in dementia with Lewy bodies","volume":"358","author":"Llorens","year":"2015","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.2967\/jnumed.112.115006","article-title":"Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data","volume":"54","author":"Lundqvist","year":"2013","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib31","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","article-title":"Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus","volume":"291","author":"Meigs","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3233\/JAD-141200","article-title":"Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia","volume":"42","author":"Nagga","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib35","doi-asserted-by":"crossref","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","article-title":"Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in\u00a0vitro blood-brain barrier model","volume":"286","author":"Nishitsuji","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib37","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib38","doi-asserted-by":"crossref","first-page":"13863","DOI":"10.1073\/pnas.1304529110","article-title":"TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1","volume":"110","author":"Qi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/jcbfm.2015.164","article-title":"The neuropathology and cerebrovascular mechanisms of dementia","volume":"36","author":"Raz","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib40","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1523\/JNEUROSCI.2810-14.2015","article-title":"Delayed inhibition of VEGF signaling after stroke attenuates blood-brain barrier breakdown and improves functional recovery in a comorbidity-dependent manner","volume":"35","author":"Reeson","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2014a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/jnnp.2003.019422","article-title":"Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications","volume":"75","author":"Sjogren","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib45","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.50.4.966","article-title":"A\u00a0population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia","volume":"50","author":"Skoog","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib46","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","article-title":"Vascular contributions to cognitive impairment and dementia including Alzheimer's disease","volume":"11","author":"Snyder","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib48","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/jcbfm.2015.167","article-title":"Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice","volume":"35","author":"Suzuki","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib49","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/STROKEAHA.110.611731","article-title":"Blood-brain barrier permeability abnormalities in vascular cognitive impairment","volume":"42","author":"Taheri","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2013.03.089","article-title":"Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches","volume":"62","author":"Tousoulis","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neubiorev.2014.11.022","article-title":"Blood-brain barrier impairment in dementia: current and future in\u00a0vivo assessments","volume":"49","author":"van de Haar","year":"2015","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2169\/internalmedicine.37.509","article-title":"Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio","volume":"37","author":"Wada","year":"1998","journal-title":"Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib54","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A\u00a0new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0404.1990.tb01562.x","article-title":"Blood brain barrier function in vascular dementia","volume":"81","author":"Wallin","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib56","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI9369","article-title":"VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain","volume":"106","author":"Zhang","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib58","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2016.11.017_bib59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016303049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016303049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T15:05:15Z","timestamp":1656255915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458016303049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":61,"alternative-id":["S0197458016303049"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.11.017","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}